Disclosure

3

Review clinical trials related to Disclosure. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

One-Page Truth-Telling Aid for Cancer Disclosure

The goal of this clinical trial is to learn whether a one-page communication aid can improve communication between physicians and patients with cancer during cancer-related truth-telling consultations. The one-page aid is designed to help physicians quickly understand patients' preferences and needs before the consultation. The main questions it aims to answer are: * Does the one-page communication aid improve patients' satisfaction with how cancer-related information is explained? * Does the one-page communication aid reduce patients' emotional distress after the consultation? * Does the one-page communication aid improve physicians' confidence in communicating cancer-related information? Researchers will compare patients whose physicians receive the one-page communication aid with patients whose physicians provide usual care with a blank sheet for patients to write down questions. This comparison will help determine whether the one-page aid improves communication, emotional outcomes, and physician confidence. Participants will: * Complete questionnaires before and after the consultation * Receive either the one-page communication aid or a blank sheet, depending on their physician's group * Complete follow-up questionnaires at 3 months and 6 months after the consultation Physicians will also complete brief questionnaires about their communication confidence at baseline, 1 week after recruitment of their first enrolled patient, 3 months, and 6 months.

Participants needed: 400
Trial details
Biological sex: AllType: InterventionalSponsor: Chang Gung UniversityUpdated: Jul 28, 2026Locations: 1
Eligibility criteria

Physicians who provide clinical care for patients with cancer in participating o... [+2]

Physicians who are unable or unwilling to complete study procedures or follow-up... [+8]

Status: Recruiting

AI-Driven Consent Simplification Study

The overarching goal of this pilot is to explore how generative artificial intelligence (genAI) can be used to improve the accessibility and understandability of informed consent materials in clinical research. The study will test the extent to which informed consent text can be improved by large language models (LLM; specifically, ChatGPT and NotebookLM) along with other AI tools (specifically, ElevenLabs) through qualitative and quantitative analyses. Simplifying such forms using genAI may facilitate better comprehension, ensuring truly informed consent. Improving informed consent form (ICF) comprehension can lead to more informed and willing participation in clinical studies. This improved understanding may result in higher enrollment rates, better subject retention, and more accurate data collection as individuals will have a clearer understanding of study procedures and risks.

Participants needed: 230
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University of California, Los AngelesUpdated: May 8, 2026Locations: 1
Eligibility criteria

Age 60 years and above [+9]

Group 1: None [+2]

Status: Recruiting

Honest Open Proud for Psychotic and Bipolar Disorder in Norway

The purpose of this pilot study is to evaluate the feasibility, acceptability and efficacy of a Norwegian adaptation of the group-based intervention 'Honest Open Proud' among adults with psychotic and bipolar disorders in an outpatient setting.

Participants needed: 40
Trial details
Age: 18-65Biological sex: AllType: InterventionalSponsor: Oslo University HospitalUpdated: May 2, 2024Locations: 2
Eligibility criteria

Diagnosed current psychotic (F 20) or bipolar disorder (F 30) according to Inter... [+4]

Intellectual disability [+1]